These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 16875622
21. [Pre-operative endoscopic infusions of an adsorbent containing mitomycin C (MMC-CH44) in stomach cancer]. Hagiwara A, Takahashi T, Ueda T, Takeda M, Lee R, Mizuguchi N. Gan To Kagaku Ryoho; 1983 Dec; 10(12):2558-64. PubMed ID: 6418078 [Abstract] [Full Text] [Related]
22. [Results of intraperitoneal active charcoal-mitomycin C therapy of stomach carcinoma with serosa invasion]. Fass J, Jansen M, Zengel K, Reinecke T, Asshoff G, Schumpelick V. Langenbecks Arch Chir Suppl Kongressbd; 1998 Dec; 115():1363-6. PubMed ID: 9931883 [Abstract] [Full Text] [Related]
23. [Experimental hyperthermo-chemotherapy for human gastric carcinoma transplanted in the nude mice]. Fujimoto S, Shrestha RD, Miyazaki M, Endoh F, Shimura T, Sugasawa H, Takahashi O, Kawata S, Ohta M, Kurihara M. Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2724-8. PubMed ID: 6439123 [Abstract] [Full Text] [Related]
24. [The selective cytotoxicity of monoclonal antibody conjugated with mitomycin C on human gastric cancer cells]. Liang YY, Wang NQ, Li N, Cui JQ, Dong ZW. Yao Xue Xue Bao; 1989 Dec; 24(11):801-6. PubMed ID: 2618675 [Abstract] [Full Text] [Related]
25. [Effect of targeting treatment of mitomycin C immunoconjugate on stomach neoplasm]. Chen LJ, Zhang SY, Zhang JL, Zhang Z, Li S, Chen M, Zhang XY, Chen XT. Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):572-6. PubMed ID: 8010062 [Abstract] [Full Text] [Related]
26. Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice. Fujita T, Tamura T, Yamada H, Yamamoto A, Muranishi S. J Drug Target; 1997 Nov; 4(5):289-96. PubMed ID: 9169985 [Abstract] [Full Text] [Related]
27. [Chemosensitivity to mitomycin C and cell kinetics of human tumor xenografts serially transplanted into nude mice]. Nakada M. Nihon Geka Gakkai Zasshi; 1984 Jul; 85(7):694-704. PubMed ID: 6436678 [Abstract] [Full Text] [Related]
28. [Intraoperative and postoperative intra-peritoneal administration of peptide PIII inhibits peritoneal metastasis of gastric cancer]. Bai FH, Yang L, Ji Q, Zhang YQ, Liu ZX, Wang ZZ, Yan L, Wang JB, Jin HF, Li TT. Zhonghua Yi Xue Za Zhi; 2006 Dec 12; 86(46):3260-3. PubMed ID: 17313805 [Abstract] [Full Text] [Related]
29. Mitomycin C and cisplatin increase survival in a human pancreatic cancer metastatic model. Tomikawa M, Kubota T, Matsuzaki SW, Takahasi S, Kitajima M, Moosa AR, Hoffman RM. Anticancer Res; 1997 Dec 12; 17(5A):3623-5. PubMed ID: 9413214 [Abstract] [Full Text] [Related]
30. Animal experiments as a model for clinical trials of a new dosage form of mitomycin C for peritoneal carcinomatosis. Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Itoh T. In Vivo; 1987 Dec 12; 1(1):43-6. PubMed ID: 2979763 [Abstract] [Full Text] [Related]
31. Effects of intraperitoneal mitomycin C adsorbed on activated carbon on adhesion formation and mesothelial cells in vitro. Jansen M, Fass J, Langejürgen E, Forsch S, Tietze L, Schumpelick V. Eur J Surg; 2000 Jul 12; 166(7):572-6. PubMed ID: 10965838 [Abstract] [Full Text] [Related]
32. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development. Phillips RM, Burger AM, Loadman PM, Jarrett CM, Swaine DJ, Fiebig HH. Cancer Res; 2000 Nov 15; 60(22):6384-90. PubMed ID: 11103802 [Abstract] [Full Text] [Related]
33. [Intraoperative chemotherapy against peritoneal dissemination of gastric cancer with intraperitoneal activated carbon particles adsorbing mitomycin C]. Hagiwara A, Takahashi T, Sawai K, Yamaguchi T, Iwamoto A, Yoneyama C. Gan To Kagaku Ryoho; 1989 Feb 15; 16(2):187-92. PubMed ID: 2493221 [Abstract] [Full Text] [Related]
34. [Effect of combination of glutamine and mitomycin C on human gastric carcinoma cell strain MGC-803]. Peng WZ, Yu JC, Liu YQ, Kang WM, Fan YP, Guo WD, Zhang Q. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun 15; 28(3):345-9. PubMed ID: 16900630 [Abstract] [Full Text] [Related]
35. Potentiation of antitumor activity of mitomycin C by estradiol: studies of human breast carcinoma xenografts serially transplanted into nude mice. Oka S, Kubota T, Takeuchi T, Kitajima M. J Surg Oncol; 1996 Apr 15; 61(4):256-61. PubMed ID: 8627994 [Abstract] [Full Text] [Related]
36. Specific targeting of mitomycin C to tumors by anti-gastric cancer monoclonal antibody. Li S, Zhang XY, Chen XT, Fan DM, Zhan SY, Chen LJ, Shu YH, Zhang JL. Chin Med J (Engl); 1991 May 15; 104(5):358-62. PubMed ID: 1908761 [Abstract] [Full Text] [Related]
37. Toxicity and pathological effects of a new dosage form of mitomycin C for carcinomatous peritonitis. Hagiwara A, Takahashi T, Ueda T, Lee R, Takeda M, Itoh T. Anticancer Res; 1987 May 15; 7(1):105-8. PubMed ID: 3105418 [Abstract] [Full Text] [Related]
38. [Experimental study on local attachment of Beriplast P membrane including MMC]. Takahashi Y, Minami S, Ohta T, Suga T, Fujioka N, Mai M. Gan To Kagaku Ryoho; 1991 Aug 15; 18(11):1944-6. PubMed ID: 1908661 [Abstract] [Full Text] [Related]
39. [Comparative study on the anticancer activities of KW2149 and mitomycin C against human tumor xenografts using subrenal capsule assay]. Takagami S, Nishiyama M, Kim R, Kirihara Y, Jinushi K, Saeki K, Saeki T, Nosoh Y, Niimoto M, Hattori T. Gan To Kagaku Ryoho; 1989 Jun 15; 16(6):2189-93. PubMed ID: 2500067 [Abstract] [Full Text] [Related]
40. Evaluation of antitumor and toxic side effects of mitomycin C-estradiol conjugates. Ishiki N, Onishi H, Machida Y. Int J Pharm; 2004 Jul 26; 279(1-2):81-93. PubMed ID: 15234797 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]